(Q40781423)

English

Effect of an EGF-R selective tyrosine kinase inhibitor and an anti-androgen on LNCaP cells: identification of divergent growth regulatory pathways

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Effect of an EGF-R selective tyrosine kinase inhibitor and an anti-androgen on LNCaP cells: identification of divergent growth regulatory pathways (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

author name string

Jones HE

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Barrow D

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Dutkowski CM

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Goddard L

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Smith C

5

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Harper ME

6

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Nicholson RI

7

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

publication date

1 September 2001

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

49

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

38-47

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Growth factors, receptors, and molecular alterations in pancreatic cancer. Putting it all together

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Crosstalk between the insulin-like growth factors and estrogens in breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Fibroblast growth factor 2: its structure and property, paracrine function, tumor angiogenesis, and prostate-related mitogenic and oncogenic functions

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

The effects of insulin-like growth factors on tumorigenesis and neoplastic growth

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Epidermal growth factor-related peptides and their receptors in human malignancies

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Epidermal growth factor receptor expression by Northern analysis and immunohistochemistry in benign and malignant prostatic tumours

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Autocrine regulation of DU145 human prostate cancer cell growth by epidermal growth factor-related polypeptides

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Signal transduction by receptors with tyrosine kinase activity

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Epidermal growth factor receptor tyrosine kinase. Investigation of catalytic mechanism, structure-based searching and discovery of a potent inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Tyrosine kinase inhibitors targeted to the epidermal growth factor receptor subfamily: role as anticancer agents

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Specific inhibition of epidermal growth factor receptor tyrosine kinase by 4-anilinoquinazolines

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Inhibition of transforming growth factor alpha (TGF-alpha)-mediated growth effects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

New EGF-R selective tyrosine kinase inhibitor reveals variable growth responses in prostate carcinoma cell lines PC-3 and DU-145.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Production of epidermal growth factor and transforming growth factor-alpha by the androgen-responsive LNCaP human prostate cancer cell line

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Growth factors in human prostate cancer cells: implications for an improved treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Divergent responses to epidermal growth factor in hormone sensitive and insensitive human prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Unliganded epidermal growth factor receptor dimerization induced by direct interaction of quinazolines with the ATP binding site.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Overexpression of EGFR and c-erbB2 causes enhanced cell migration in human breast cancer cells and NIH3T3 fibroblasts

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Tyrosine kinase inhibitor as a novel signal transduction and antiproliferative agent: prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Epidermal growth factor receptor signaling cascade as target for tyrphostin (RG 50864) in epithelial cells. Paradoxical effects on mitogen-activated protein kinase kinase and mitogen-activated protein kinase activities

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

The effects of dihydrotestosterone on the expression of p185(erbB-2) and c-erbB-2 mRNA in the prostatic cell line LNCaP.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Effect of growth factors on estrogen receptor mediated gene expression

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

An immunocytochemical analysis of TGFα expression in benign and malignant prostatic tumors

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Role of transforming growth factor-alpha in human prostate cancer cell growth

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Prostatic epidermal growth factor receptors and their regulation by androgens

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Epidermal growth factor receptor content in rat prostatic adenocarcinoma: effects of endocrine treatment

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1116

21 January 2018

Identifiers

10.1002/PROS.1116

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40781423&oldid=1907317849"